Treatment of Hyperpigmentation After Sclerotherapy Through Mesotherapy With Deferoxamine Mesylate: A Case Series. [PDF]
Mello Netto BAS +3 more
europepmc +1 more source
Correction: Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage. [PDF]
Li Y, Yang H, Ni W, Gu Y.
europepmc +1 more source
<p>Pathological mechanism of ferroptosis in a rat model of α‑naphthyl isothiocyanate‑induced chronic cholestasis</p>. [PDF]
Guo Z +8 more
europepmc +1 more source
Bone histologic response to deferoxamine in aluminum–related bone disease
Dennis L. Andress +7 more
openalex +1 more source
Combined thermal and mild electrical stimulations modulate heat shock protein and VEGF in retinal pigment epithelial cells under high glucose. [PDF]
Fujino R +5 more
europepmc +1 more source
Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs. [PDF]
Jerry E. Fleischer +3 more
openalex +1 more source
A case report of a 79-year-old female with aluminum toxicity presenting with altered mental status in Eldoret, Kenya. [PDF]
Mutugi A +4 more
europepmc +1 more source
Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
Alexis Donneys +12 more
openalex +1 more source

